CN101228159A - 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 - Google Patents

卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 Download PDF

Info

Publication number
CN101228159A
CN101228159A CNA200680027137XA CN200680027137A CN101228159A CN 101228159 A CN101228159 A CN 101228159A CN A200680027137X A CNA200680027137X A CN A200680027137XA CN 200680027137 A CN200680027137 A CN 200680027137A CN 101228159 A CN101228159 A CN 101228159A
Authority
CN
China
Prior art keywords
cabergoline
solvent
structural formula
solvate
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200680027137XA
Other languages
English (en)
Chinese (zh)
Inventor
A·格林伍德
D·麦克哈蒂
P·巴塔拉哈
M·阿罗伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resolution Chemicals Ltd
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of CN101228159A publication Critical patent/CN101228159A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA200680027137XA 2005-07-27 2006-07-27 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备 Pending CN101228159A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0515430.7A GB0515430D0 (en) 2005-07-27 2005-07-27 Preparation of cabergoline
GB0515430.7 2005-07-27

Publications (1)

Publication Number Publication Date
CN101228159A true CN101228159A (zh) 2008-07-23

Family

ID=34976701

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200680027137XA Pending CN101228159A (zh) 2005-07-27 2006-07-27 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备

Country Status (10)

Country Link
EP (1) EP1912984A1 (ja)
JP (1) JP2009502895A (ja)
CN (1) CN101228159A (ja)
AU (1) AU2006273831A1 (ja)
CA (1) CA2616738A1 (ja)
GB (1) GB0515430D0 (ja)
IL (1) IL188598A0 (ja)
NO (1) NO20080461L (ja)
WO (1) WO2007012846A1 (ja)
ZA (1) ZA200801151B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170095507A1 (en) * 2014-08-17 2017-04-06 Shanxi Zhendong Ante Biopharmaceutical Co., Ltd. Dispersion preparation containing colloidal bismuth pectin and preparing method therefor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
KR100605794B1 (ko) * 2002-03-15 2006-08-01 파마시아 코포레이션 카베르골린의 제1형 결정을 제조하는 방법
EP1485383A1 (en) * 2002-03-15 2004-12-15 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
CA2525104A1 (en) * 2003-05-08 2004-11-25 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170095507A1 (en) * 2014-08-17 2017-04-06 Shanxi Zhendong Ante Biopharmaceutical Co., Ltd. Dispersion preparation containing colloidal bismuth pectin and preparing method therefor

Also Published As

Publication number Publication date
ZA200801151B (en) 2009-04-29
EP1912984A1 (en) 2008-04-23
AU2006273831A1 (en) 2007-02-01
CA2616738A1 (en) 2007-02-01
IL188598A0 (en) 2008-04-13
JP2009502895A (ja) 2009-01-29
GB0515430D0 (en) 2005-08-31
WO2007012846A1 (en) 2007-02-01
NO20080461L (no) 2008-04-18

Similar Documents

Publication Publication Date Title
JP2016020353A (ja) ラキニモドナトリウムの結晶，及びその製造方法
JP2007535526A (ja) カベルゴリンの調製
EP3239165B1 (en) Composition containing nitrogen heterocyclic hexapeptide precursor and preparation method and application thereof
CN101228159A (zh) 卡麦角林溶剂化物以及卡麦角林ⅰ型的制备
CN108774217B (zh) 一种阿齐沙坦微粉原料药的制备工艺
EP2956439B1 (en) Process for preparing atazanavir sulphate
HU208009B (en) Process for diminishing cristal-dimension of ondansteron-hydrochloride-dihydrate and pharamceutical compositions containing these compounds
CN101208337A (zh) 卡麦角林的制备
CN1140510C (zh) (r)-3-[[(4-氟苯基)磺酰基]氨基]-1,2,3,4-四氢-9h-咔唑-9-丙酸(拉马曲班)的热力学稳定形式
RU2277536C2 (ru) Способ получения кристаллической формы i каберголина, сольват формы х каберголина и способ его получения
CN111454255B (zh) 一种小粒度阿齐沙坦的制备方法
CN106432201B (zh) 一种坎地沙坦酯结晶的制备方法
EP2135869A1 (en) Preparation of a crystalline form of cabergoline
CN113368115B (zh) 一种罗库溴铵的药物组合物以及罗库溴铵的精制方法
CN116509810B (zh) 一种孟鲁司特钠片剂及其制备方法
EP1883648A1 (en) Process for the preparation of pure crystalline tibolone
US20220251111A1 (en) Process for the preparation of amorphous midostaurin with a low content of residual organic solvent
CN106431943B (zh) 一种盐酸安非他酮结晶的制备方法
EP2835377B1 (en) New crystal form h of ginsenoside c-k and method for preparing same
KR20240050699A (ko) 17알파-에스트라디올의 신규 결정다형 및 이의 제조방법
EP1070083A1 (fr) Formes cristallines du 1s-[1alpha(2s*,3r*),9alpha]-6,10-dioxo-n- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]- amino]octahydro-6h-piridazino[1,2-a][1,2]diazepine-1-carboxamide
WO2007026372A2 (en) Novel crystalline polymorph of trandolapril and a process for preparation thereof
WO2014024210A2 (en) Novel polymorphs of doxercalciferol
GB2287707A (en) Production of N-(2-hydroxypropyl) methacrylamide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080723